SERUM AND KNEE SYNOVIAL FLUID MATRIXMETALLOPROTEINASE-13, TUMOR NECROSIS FACTOR-ALPHA LEVELS IN PATIENTS WITH LATE STAGE OSTEOARTHRITIS | Zendy

Kenan Özler | Zendy; Erdem Aktaş | Zendy; Çiğdem Atay | Zendy; Barış Yılmaz | Zendy; Murat Arıkan | Zendy; Şafak Güngör | Zendy

Open Access

SERUM AND KNEE SYNOVIAL FLUID MATRIXMETALLOPROTEINASE-13, TUMOR NECROSIS FACTOR-ALPHA LEVELS IN PATIENTS WITH LATE STAGE OSTEOARTHRITIS

Author(s) -

Kenan Özler,

Erdem Aktaş,

Çiğdem Atay,

Barış Yılmaz,

Murat Arıkan,

Şafak Güngör

Publication year - 2015

Publication title -

acta orthopaedica et traumatologica turcica

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.586

H-Index - 28

eISSN - 2589-1294

pISSN - 1017-995X

DOI - 10.3944/aott.2015.15.0115

Subject(s) - medicine , synovial fluid , osteoarthritis , womac , gastroenterology , stage (stratigraphy) , tumor necrosis factor alpha , arthritis , total knee arthroplasty , urology , surgery , pathology , paleontology , alternative medicine , biology

The aim of this study was to compare serum and synovial fluid levels of matrix metalloproteinase-13 (MMP-13) and tumor necrosis factor-alpha (TNF-α) in 2 stages of osteoarthritis, and investigate their correlation with Western Ontario and McMaster Universities Arthritis Index (WOMAC) scores.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research